Advanced Biologic Drugs and Manufacturing Process

Erscheinungsjahr 2024
ISBN: 978-0-443-15640-3
Verlag: Elsevier Science

Buch, Englisch, 244 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 450 g

Advanced Biologic Drugs and Manufacturing Process explains biologic drugs, their pharmaceutical charters, and their significance in curing life-threatening chronic diseases. It also provides the latest information on the use of biological drugs for the treatment of numerous diseases and conditions and their most advanced therapies available, including how biologics have impacted cancer therapy, delayed or reversed the course of immune-related conditions, and changed the lives of those with rare chronic diseases. In addition, the book explains how immunotherapy is used for the treatment of diseases by activating or suppressing the immune system.

Scientists working on the front lines in the biotechnology industry are provided with an overview on stable production processes and how to monitor the value chain transfer process of biologic drug for better return, in terms of profit. The book also helps researchers and academics on how to develop and update protocols related to testing, quality control, and quality assurance to obtain highly purified biopharmaceuticals or vaccines.

Autoren/Hrsg.

Behera, Basanta Kumara

Fachgebiete

• Naturwissenschaften Biowissenschaften Mikrobiologie

Inhaltsverzeichnis

1. Process Initiation

2. Regeneration Medicine

3. Portfolio strategic of biopharmaceutical companies

4. Immunotherapeutic proteins

5. Biologic from mammalian and non-mammalian cell lines

6. Personalized medicine

7. Bionanotechnology

Über Autor(innen)

Behera, Basanta Kumara
Dr. Basanta Kumara Behera was a Professor of Biotechnology at three distinguished Indian universities, where he taught and conducted research at the post-graduate level on medical biotechnology, biopharmaceutical, microbial process development, drug designing, bio-energy management, and biomass processing technology since 1978. In 2009, he joined an MNC company as an advisor for specialty chemicals production and drug design through microbial process technology. He is associated with national and international companies as a technical advisor to produce biopharmaceuticals under cGMP norms. Dr. Behera has authored and edited books with various publishers worldwide.